Parametric CC Dev World exUS ESG ADR-TMW (S:0P0001DH4V)
16.55
-1.02
(-5.82%)
USD |
Oct 31 2024
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Maximum Management Fee | Annualized Total Returns Since Inception (Daily) | Alpha (vs Category) (3Y) | Forecasted Dividend Yield |
---|---|---|---|
-- | -- | -- | -- |
Total Market Value (Net) | Beta (vs Category) (3Y) | Max Drawdown (Since Inception) | Fwd Dividend Yield (Long) |
Upgrade | Upgrade | Upgrade | Upgrade |
Basic Info
Investment Strategy | |
General | |
Security Type | |
Equity Style | |
Fixed Income Style | |
Broad Asset Class | |
Broad Category | |
Category Name | |
Category Index | |
Global Category Name | |
YCharts Categorization | Global Equity |
YCharts Benchmark | MSCI World Total Return (^MSWTR) |
Fund Owner Firm Name |
Prospectus Benchmark Index | |
MSCI World ex USA ESG Leaders NR USD | 100.0% |
Broad Asset Class Benchmark Index | |
100.0% | |
Manager Tenure | |
Paul Bouchey | 8.01 yrs |
Thomas Seto | 8.01 yrs |
Jennifer Sireklove | 5.34 yrs |
Thomas Lee | 5.01 yrs |
Jeremy Milleson | 3.34 yrs |
Annual Total Returns Versus Peers
As of November 23, 2024.
Asset Allocation
Type | % Net | % Long | % Short |
---|---|---|---|
Cash | -- | -- | -- |
Stock | -- | -- | -- |
Bond | -- | -- | -- |
Convertible | -- | -- | -- |
Preferred | -- | -- | -- |
Other | -- | -- | -- |
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Novo Nordisk AS ADR | 3.98% | 105.06 | 2.37% |
ASML Holding NV ADR | 3.38% | 672.88 | 0.11% |
AstraZeneca PLC ADR | 2.47% | 65.63 | 2.13% |
Novartis AG ADR | 2.22% | 104.28 | 0.41% |
Lvmh Moet Hennessy Louis Vuitton SE ADR | 2.13% | 121.30 | 0.65% |
Unilever PLC ADR | 1.83% | 58.61 | 1.70% |
Schneider Electric SE ADR | 1.73% | 50.33 | -0.14% |
HSBC Holdings PLC ADR | 1.67% | 45.94 | -0.82% |
TotalEnergies SE ADR | 1.56% | 59.66 | -0.62% |
Sony Group Corp ADR | 1.36% | 19.06 | -0.05% |
Fees & Availability
Fees | |
Negotiable Fee | No |
Administrative Fee | -- |
Maximum Management Fee | -- |
Prospectus Custodian Fee | -- |
Trustee Fee | -- |
Purchase Details | |
Open to New Investors | No |
Open to Existing Investors | No |
Minimum Initial Investment | -- |
Minimum Subsequent Investment | -- |
Basic Info
Investment Strategy | |
General | |
Security Type | |
Equity Style | |
Fixed Income Style | |
Broad Asset Class | |
Broad Category | |
Category Name | |
Category Index | |
Global Category Name | |
YCharts Categorization | Global Equity |
YCharts Benchmark | MSCI World Total Return (^MSWTR) |
Fund Owner Firm Name |
Prospectus Benchmark Index | |
MSCI World ex USA ESG Leaders NR USD | 100.0% |
Broad Asset Class Benchmark Index | |
100.0% | |
Manager Tenure | |
Paul Bouchey | 8.01 yrs |
Thomas Seto | 8.01 yrs |
Jennifer Sireklove | 5.34 yrs |
Thomas Lee | 5.01 yrs |
Jeremy Milleson | 3.34 yrs |
Fundamentals
Number of Holdings | -- |
Stock | |
Weighted Average PE Ratio | -- |
Weighted Average Price to Sales Ratio | -- |
Weighted Average Price to Book Ratio | -- |
Weighted Median ROE | -- |
Weighted Median ROA | -- |
Forecasted Dividend Yield | -- |
Forecasted PE Ratio | -- |
Forecasted Price to Sales Ratio | -- |
Forecasted Price to Book Ratio | -- |
Fund Details
Key Dates | |
Inception Date | -- |
Last Annual Report Date | -- |
Last Prospectus Date | -- |
Attributes | |
Index Fund | No |
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |